DUX4 and facioscapulohumeral muscular dystrophy: While FSHD is an autosomal dominant gain-of-function disease, the pathogenic DUX4 gene is typically expressed in only a small fraction (< 1%) of cells, ultimately leading to debilitating muscle pathology over time [9, 18, 28].